ID: ALA245895

Max Phase: Preclinical

Molecular Formula: C25H24ClNO4S

Molecular Weight: 469.99

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(OC(=O)Nc1ccccc1-c1ccc(CSCCC(=O)O)cc1)c1ccccc1Cl

Standard InChI:  InChI=1S/C25H24ClNO4S/c1-17(20-6-2-4-8-22(20)26)31-25(30)27-23-9-5-3-7-21(23)19-12-10-18(11-13-19)16-32-15-14-24(28)29/h2-13,17H,14-16H2,1H3,(H,27,30)(H,28,29)

Standard InChI Key:  AVXXLUPPYOJIOV-UHFFFAOYSA-N

Associated Targets(Human)

Lysophosphatidic acid receptor Edg-2 779 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lysophosphatidic acid receptor Edg-2 62 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 469.99Molecular Weight (Monoisotopic): 469.1115AlogP: 7.02#Rotatable Bonds: 9
Polar Surface Area: 75.63Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.73CX Basic pKa: CX LogP: 6.70CX LogD: 4.09
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.33Np Likeness Score: -1.05

References

1. Yamamoto T, Fujita K, Asari S, Chiba A, Kataba Y, Ohsumi K, Ohmuta N, Iida Y, Ijichi C, Iwayama S, Fukuchi N, Shoji M..  (2007)  Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists.,  17  (13): [PMID:17467986] [10.1016/j.bmcl.2007.04.024]

Source